Blue Bell Private Wealth Management »

Ishares Tr genomics immun shares owned by Blue Bell Private Wealth Management

Quarter-by-quarter ownership of Ishares Tr genomics immun (IDNA) shares owned by Blue Bell Private Wealth Management from 13F filings

Historical chart of Blue Bell Private Wealth Management investment in Ishares Tr genomics immun

Tip: Access up to 7 years of quarterly data

All positions including Ishares Tr genomics immun held by Blue Bell Private Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ishares Tr genomics immun by Blue Bell Private Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.6k 110 24.08
2023-12-31 $2.5k 110 23.01
2023-09-30 $2.2k 110 20.35
2023-06-30 $2.6k 110 23.35
2023-03-31 $2.6k 110 23.27
2021-12-31 $1.0k 20 50.00

More positions owned by Blue Bell Private Wealth Management

Spdr S&p 500 Etf Trust Etf (SPY)
General Amern Invs Cef (GAM)
Adams Diversified Equity Cef (ADX)
Schwab U.s. Large-cap Etf Etf (SCHX)
Schwab U.s. Broad Market Etf Etf (SCHB)
Tri Contl Corp Cef (TY)
Vanguard Total Stock Market Etf Etf (VTI)
Ishares Russell 2000 Etf Etf (IWM)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Spdr Dow Jones Industrial Average Etf Trust Etf (DIA)
Royce Value Tr Cef (RVT)
Schwab U.s. Small-cap Etf Etf (SCHA)
Allianzim U.s. Large Cap Buffer20 Oct Etf Etf (OCTW)
Ishares Core S&p 500 Etf Etf (IVV)
Vanguard S&p 500 Etf Etf (VOO)

View all positions for Blue Bell Private Wealth Management

Top funds holding Ishares Tr genomics immun

Jane Street
Wharton Business Group
Bank of America Corporation
UBS Group
Royal Bank of Canada
Bsc Private Wealth Management
Commonwealth Equity Services
Advisor Group Holdings
Cora Capital Advisors
Citadel Advisors
Visionary Wealth Advisors
Raymond James Financial Services Advisors
Branch Banking & Trust Company
TCG Advisory Services
PFG Investments

View all funds holding Ishares Tr genomics immun